BioSpace News Archive

Business

Genentech, Blueprint Ink $1 Billion+ Deal to Develop Treatment for RET-Altered Cancer

Shares of Blueprint Medicines are climbing in premarket trading after the company inked a collaboration worth more than $1 billion with Genentech to develop a treatment for cancers driven by oncogenic RET alteration.

July 14, 2020
·
3 min read
·
Alex Keown
Business

Kancera’s Unique Approach to COVID-19: Attack the Fractalkine System

Thomas Olin, chief executive officer of Kancera, took time to discuss the company, the Fracktalkine pathway and the upcoming clinical trial.

July 14, 2020
·
5 min read
·
Mark Terry
Pharm Country

New Approach May Dramatically Improve Damaged Lungs to be Used for Transplants

Scientists at Columbia University and Vanderbilt University have been working on ways to revive damaged lungs for the last eight years.

July 14, 2020
·
3 min read
·
Mark Terry
FDA

Janssen’s Tremfya Snags Approval as First IL-23 Treatment for Active Psoriatic Arthritis

In announcing the approval this morning, Janssen said IL-23 is a naturally occurring cytokine involved in normal inflammatory and immune responses associated with symptoms of psoriatic arthritis.

July 14, 2020
·
2 min read
·
Alex Keown
Policy

Biopharma Update on the Novel Coronavirus: July 15

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 15, 2020.

July 14, 2020
·
5 min read
·
BioSpace Editorial Staff
Drug Development

Medicago Kicks Off Phase I Trial for Plant-Derived COVID-19 Vaccine Candidate

It has already administered the first doses of the candidate in healthy human subjects, and the company intends to initiate a Phase II/III trial this coming October.

July 14, 2020
·
3 min read
·
Krystle Vermes
Business

Sanofi and MD Anderson Enter 5-Year Immuno-Oncology Alliance

Paris-based Sanofi and Houston-based The University of Texas MD Anderson Cancer Center entered a five-year strategic partnership to develop immune therapies and targeted cancer treatments.

July 14, 2020
·
3 min read
·
Mark Terry
Policy

U.S. Official: COVID-19 Vaccine Manufacturing Could Begin By Late Summer

An unnamed U.S. official told the news agency that vaccine manufacturing under development in conjunction with the federal government’s Operation Warp Speed program is likely to begin within the next four to six weeks.

July 14, 2020
·
2 min read
·
Alex Keown
Business

Developing an ‘Inverse Vaccine’ for Type 1 Diabetes

What do you get when you mix certain immune cells with vitamin D and a disease-provoking molecule? An innovative new vaccine for type 1 diabetes.

July 14, 2020
·
6 min read
·
Chelsea Weidman Burke
Munich and Boston-Based Viral Vector Pioneer Achieves 26% Growth for H1 2020 Despite COVID-19 Pandemic

SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene and cell therapy, announced financial results for the first half of 2020.

July 14, 2020
·
3 min read